Insider trades
Ralph Niven, Chief Officer of Jade Biosciences JBIO, has filed 0 purchases and 16 sales on the open market. The latest trade was on 24/02/05.
Ralph Niven
Chief Scientific Officer
- Company
- Jade Biosciences JBIO
- First filing
- 23/01/09
- Trades
- 95 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- No record
- Last trade
- 24/02/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 24/02/05 | 24/02/07 | 4,600 sh | $17.45 | $80,270 | −74.1% |
JBIO | Open-market sale10b5-1 plan | 24/01/05 | 24/01/08 | 4,600 sh2 trades | $19.15avg. | $88,108.6 | −74.1% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 23/12/05 | 23/12/07 | 4,600 sh | $16.30 | $74,980 | −74.1% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 23/11/22 | 23/11/27 | 13,800 sh | $15.00 | $207,000 | −89.6% |
JBIO | Open-market sale10b5-1 plan | 23/07/05 | 23/07/07 | 2,250 sh2 trades | $17.29avg. | $38,907.66 | −58.3% |
Jade BiosciencesJBIO | Open-market sale10b5-1 plan | 23/06/05 | 23/06/07 | 2,250 sh | $16.26 | $36,585 | −58.3% |
JBIO | Open-market sale10b5-1 plan | 23/05/05 | 23/05/09 | 2,250 sh2 trades | $20.87avg. | $46,949.7 | −58.3% |
JBIO | Open-market sale | 23/04/05 | 23/04/07 | 2,250 sh2 trades | $18.20avg. | $40,939.5 | −58.3% |
JBIO | Open-market sale | 23/03/06 | 23/03/08 | 2,250 sh2 trades | $23.75avg. | $53,446.05 | −58.3% |
Jade BiosciencesJBIO | Open-market sale | 23/02/06 | 23/02/08 | 2,250 sh | $24.27 | $54,607.5 | −58.3% |
Jade BiosciencesJBIO | Open-market sale | 23/01/05 | 23/01/09 | 2,250 sh | $26.40 | $59,400 | −58.3% |